Literature DB >> 8828924

Characterization of N1- and N6-adenosine adducts and N1-inosine adducts formed by the reaction of butadiene monoxide with adenosine: evidence for the N1-adenosine adducts as major initial products.

R R Selzer1, A A Elfarra.   

Abstract

1,3-Butadiene is a known human mutagen and possible human carcinogen; however, the molecular mechanisms of its activity are poorly understood. We have previously shown that the primary metabolite, butadiene monoxide (BM), reacts with guanosine to form N1-, N2-, and N7-guanosine adducts. In this study we characterize the reaction of BM with adenosine; ten adducts identified as diastereomeric pairs of N1-(1-hydroxy-3-buten-2-yl)adenosine,N1-(2-hydroxy-3-buten-1 -yl)adenosine, N6-(1-hydroxy-3-buten-2-yl)adenosine,N6-(2-hydroxy-3-buten-+ ++1yl)adenosine, and N1-(1-hydroxy-3-buten-2-yl)inosine are characterized. The N6-adenosine and N1-inosine adducts were characterized by their UV spectra, 1H NMR, FAB/MS, and stability studies. The N6-adenosine and N1-inosine adducts were stable for up to 168 h at 37 degrees C in phosphate buffer (pH 7.4). The N1-adenosine adducts, which were unstable at pH 7.4 at 37 degrees C (half-life of 7 and 9.5 h for the two regioisomers), were characterized by their UV spectra and their ability to undergo the Dimroth rearrangement to yield the corresponding N6-adenosine adducts, or undergo deamination to yield the corresponding N1-inosine adducts. Upon the reaction of BM with adenosine in phosphate buffer (pH 7.4) at 37 degrees C, the N1-adenosine adducts were the first to be detected, with the N6-adenosine and N1-inosine adducts. showing a lag in formation possibly due to the time needed for rearrangement/deamination. Reaction of adenosine with an excess of BM in phosphate buffer (pH 7.4) at 37 degrees C, followed by extraction of the reaction mixture with ethyl ether to remove excess unreacted BM and incubation at 80 degrees C for 1 h, resulted in complete conversion of N1-adenosine adducts to the corresponding N6-adenosine and N1-inosine adducts. Under these conditions, adduct formation exhibited pseudo-first-order kinetics, with the combined N6-adenosine adducts being formed 3-fold more favorably than the combined N1-inosine adducts. When incubations were carried out at lower BM concentrations, the N6-adenosine adducts remained the major detectable adducts at all concentrations. These results show that adenosine, in addition to guanosine, can lead to multiple adducts when incubated with BM, and may be useful in development of biomarkers for exposure to 1,3-butadiene. Characterization of the N1-adenosine adducts and their rearrangement/deamination products may also contribute to the understanding of mutagenic and carcinogenic mechanisms of 1,3-butadiene.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828924     DOI: 10.1021/tx960039a

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  13 in total

1.  Structure of the 1,4-bis(2'-deoxyadenosin-N6-yl)-2R,3R-butanediol cross-link arising from alkylation of the human N-ras codon 61 by butadiene diepoxide.

Authors:  W Keither Merritt; Lubomir V Nechev; Tandace A Scholdberg; Stephen M Dean; Sarah E Kiehna; Johanna C Chang; Thomas M Harris; Constance M Harris; R Stephen Lloyd; Michael P Stone
Journal:  Biochemistry       Date:  2005-08-02       Impact factor: 3.162

2.  Mutagenicity of a glutathione conjugate of butadiene diepoxide.

Authors:  Sung-Hee Cho; Elisabeth M Loecken; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2010-09-29       Impact factor: 3.739

3.  Analysis and Identification of 2'-Deoxyadenosine-Derived Adducts in Lung and Liver DNA of F-344 Rats Treated with the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol.

Authors:  Erik S Carlson; Pramod Upadhyaya; Peter W Villalta; Bin Ma; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2018-04-19       Impact factor: 3.739

4.  Conjugation of butadiene diepoxide with glutathione yields DNA adducts in vitro and in vivo.

Authors:  Sung-Hee Cho; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-01-09       Impact factor: 3.739

Review 5.  Chemistry and structural biology of DNA damage and biological consequences.

Authors:  Michael P Stone; Hai Huang; Kyle L Brown; Ganesh Shanmugam
Journal:  Chem Biodivers       Date:  2011-09       Impact factor: 2.408

6.  Identification and characterization of 2'-deoxyadenosine adducts formed by isoprene monoepoxides in vitro.

Authors:  Petra Begemann; Gunnar Boysen; Nadia I Georgieva; Ramiah Sangaiah; Karl M Koshlap; Hasan Koc; Daping Zhang; Bernard T Golding; Avram Gold; James A Swenberg
Journal:  Chem Res Toxicol       Date:  2011-06-09       Impact factor: 3.739

7.  Dual roles of glycosyl torsion angle conformation and stereochemical configuration in butadiene oxide-derived N1 beta-hydroxyalkyl deoxyinosine adducts: a structural perspective.

Authors:  W Keither Merritt; Agnieszka Kowalczyk; Tandace A Scholdberg; Stephen M Dean; Thomas M Harris; Constance M Harris; R Stephen Lloyd; Michael P Stone
Journal:  Chem Res Toxicol       Date:  2005-07       Impact factor: 3.739

8.  Exocyclic deoxyadenosine adducts of 1,2,3,4-diepoxybutane: synthesis, structural elucidation, and mechanistic studies.

Authors:  Uthpala Seneviratne; Sergey Antsypovich; Melissa Goggin; Danae Quirk Dorr; Rebecca Guza; Adam Moser; Carrie Thompson; Darrin M York; Natalia Tretyakova
Journal:  Chem Res Toxicol       Date:  2010-01       Impact factor: 3.739

9.  In vivo roles of conjugation with glutathione and O6-alkylguanine DNA-alkyltransferase in the mutagenicity of the bis-electrophiles 1,2-dibromoethane and 1,2,3,4-diepoxybutane in mice.

Authors:  Sung-Hee Cho; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-11-06       Impact factor: 3.739

10.  Mutagenic bypass of the butadiene-derived 2'-deoxyuridine adducts by polymerases eta and zeta.

Authors:  Priscilla H Fernandes; R Stephen Lloyd
Journal:  Mutat Res       Date:  2007-05-18       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.